🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchTRIUMPH program (retatrutide) — my results so far Page 3

TRIUMPH program (retatrutide) — my results so far

BenResearch_OR Fri, Jan 31, 2025 at 9:18 PM 42 replies 1,987 viewsPage 3 of 9
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Feb 5, 2025 at 6:13 AM#11
Dr.PathRoch said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

38 11JakeSmashed95, NauseaFreeNow, SteveThurs and 35 others
Reply Quote Save Share Report
marcus_mpls
Member
234
1,123
Nov 2024
Minneapolis, MN
Feb 5, 2025 at 1:14 PM#12
LibrarianMeg said:
The glucagon component looks paradoxical and is not.

That reframing is the part I needed. Adding it to my notes with a link back to this thread.

39 12oliver_london, tane_welly, Dr.PathRoch and 36 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Feb 5, 2025 at 8:14 PM#13
Dr.PathRoch said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Pushing back on Dr.PathRoch here. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

40 13HealthEcon_DC, PedsEndoPhilly, SleepDoc_PDX and 37 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Feb 6, 2025 at 3:14 AM#14

The figures, for anyone assembling their own picture. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

41 14ben_calgary, patPC_UT, Dr.DermMIA and 38 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Feb 6, 2025 at 10:14 AM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Carry on.

Last edited: Feb 6, 2025 at 12:14 PM
42 15PurityPaulOR, MaxMetOK, MounjBrad and 39 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register